PHLDA3 impedes somatic cell reprogramming by activating Akt-GSK3β pathway
Abstract Reprogramming of adult somatic cells into induced pluripotent stem cells holds great promise in clinical therapy. Increasing evidences have shown that p53 and its target genes play important roles in somatic cell reprogramming. In this study, we report that PHLDA3, a p53 target gene, functi...
Enregistré dans:
Auteurs principaux: | Mengran Qiao, Mian Wu, Ronghua Shi, Wanglai Hu |
---|---|
Format: | article |
Langue: | EN |
Publié: |
Nature Portfolio
2017
|
Sujets: | |
Accès en ligne: | https://doaj.org/article/46b8c69175644bd1a57a0477d1d5901d |
Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|
Documents similaires
-
TRIM21 and PHLDA3 negatively regulate the crosstalk between the PI3K/AKT pathway and PPP metabolism
par: Jie Cheng, et autres
Publié: (2020) -
Milk Exosome-Derived MicroRNA-2478 Suppresses Melanogenesis through the Akt-GSK3β Pathway
par: In-Seon Bae, et autres
Publié: (2021) -
Huaier aqueous extract inhibits ovarian cancer cell motility via the AKT/GSK3β/β-catenin pathway.
par: Xiaohui Yan, et autres
Publié: (2013) -
Gα13 negatively controls osteoclastogenesis through inhibition of the Akt-GSK3β-NFATc1 signalling pathway
par: Mengrui Wu, et autres
Publié: (2017) -
Mitochondrial Akt Signaling Modulated Reprogramming of Somatic Cells
par: Yu-Han Chen, et autres
Publié: (2019)